Wakamoto Pharmaceutical Co.,Ltd.

Tokyo Stock Exchange 4512.T

Wakamoto Pharmaceutical Co.,Ltd. Market Capitalization on January 29, 2025: USD 48.72 M

Wakamoto Pharmaceutical Co.,Ltd. Market Capitalization is USD 48.72 M on January 29, 2025, a -3.10% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Wakamoto Pharmaceutical Co.,Ltd. 52-week high Market Capitalization is USD 72.51 M on September 24, 2024, which is 48.84% above the current Market Capitalization.
Wakamoto Pharmaceutical Co.,Ltd. 52-week low Market Capitalization is USD 46.41 M on March 05, 2024, which is -4.73% below the current Market Capitalization.
Wakamoto Pharmaceutical Co.,Ltd. average Market Capitalization for the last 52 weeks is USD 53.94 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Tokyo Stock Exchange: 4512.T

Wakamoto Pharmaceutical Co.,Ltd.

CEO	Mr. Arata Igarashi
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	2-2-2, Nihonbashi Honcho
Employees	403
Sector	Health Care
Industries Pharmaceuticals

Description

Wakamoto Pharmaceutical Co., Ltd. manufactures and sells ethical and non-prescription drugs in Japan. The company offers Strong Wakamoto, a gastrointestinal drug for digestion, intestinal regulation, and nutritional supplementation. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co., Ltd. in July 1943. Wakamoto Pharmaceutical Co., Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years